Companies / Health Care / Health Care Equipment
Dexcom stock buybacks
DXCM$1.1Bbought back in the 12 months to Jun 30, 2026 (from the statement of stockholders' equity)
Dexcom bought back $1.1B of its stock in the last twelve months, $947M more than it paid out in stock compensation. Its share count is down 4.4% from a year earlier.
Show as table
| Period | Value |
|---|---|
| Q3 '22 | $557.7M |
| Q4 '22 | $0 |
| Q1 '23 | $0 |
| Q2 '23 | $189.1M |
| Q3 '23 | $0 |
| Q4 '23 | $0 |
| Q1 '24 | $0 |
| Q2 '24 | $0 |
| Q3 '24 | $749.5M |
| Q4 '24 | $0 |
| Q1 '25 | $0 |
| Q2 '25 | $0 |
| Q3 '25 | $187.7M |
| Q4 '25 | $315.9M |
| Q1 '26 | $0 |
| Q2 '26 | $605.6M |
Show as table
| Period | Value |
|---|---|
| Q3 '22 | 425.8M |
| Q4 '22 | 434.1M |
| Q1 '23 | 418.5M |
| Q2 '23 | 431.5M |
| Q3 '23 | 426.8M |
| Q4 '23 | 425.2M |
| Q1 '24 | 416.7M |
| Q2 '24 | 416.8M |
| Q3 '24 | 410.2M |
| Q4 '24 | 407.1M |
| Q1 '25 | 407.5M |
| Q2 '25 | 408.2M |
| Q3 '25 | 407.4M |
| Q4 '25 | 398.9M |
| Q1 '26 | 393.6M |
| Q2 '26 | 390.1M |
$606Mlast quarter (Q2 2026)
$947Mnet of stock compensation ($162M)
−4.4%diluted shares, 1 year
−3.5%diluted shares, 5 years
—dividends, 12 months
79%of free cash flow ($1.4B) spent on buybacks
$27Mraised by issuing stock, 12 months
377.4Mshares outstanding (Jul 23, 2026)
Share counts are adjusted for 6 stock splits (1-for-4, 4-for-1, 1-for-4, 4-for-1, 1-for-4, 4-for-1).
By fiscal year
Questions
- Does Dexcom buy back its stock?
- Dexcom bought back $1.1B of its stock in the last twelve months, $947M more than it paid out in stock compensation. Its share count is down 4.4% from a year earlier.
- How much did Dexcom spend on buybacks in fiscal 2025?
- $500M, according to its 10-K for the fiscal year ending Dec 31, 2025.
- Is Dexcom's share count going down?
- Its diluted share count changed −3.5% over five fiscal years and −4.4% over the last year.
Latest filing used: 10-Q for the period ending Jun 30, 2026, filed Jul 30, 2026 · open on SEC.gov